ADVERTISEMENT

Stay up to date every week with the european biotechnology newsletter.

✕
This field is hidden when viewing the form
EBcom NL
This field is hidden when viewing the form
Consent
This field is for validation purposes and should be left unchanged.

Stay up to date every week with the european biotechnology newsletter.

Log in here to read the desired article.

This field is hidden when viewing the form
EBcom NL
This field is hidden when viewing the form
Consent
This field is for validation purposes and should be left unchanged.
go to the article

go back to the homepage

  • BIOCOM CARD
  • Newsletter
  • Advertising
  • Job Market
  • Shop
European Biotechnology Magazine
biocom_logo
  • Latest news
  • Background
  • Opinion
  • The Mag
    • Issues
    • Special
    • Subscribe
  • Euro Biotech Guide
  • Market Place
    • Products
    • Sponsored Publications
    • Advertise
  • Associations
  • Service
    • Job Market
    • Newsletter
    • Contact Us
    • Editorial Team
  • Events
  • Search
  • Menu Menu

ADVERTISEMENT

Humanized NSG and NSG-SGM3 mice as a new preclinical bridge for immune-oncology therapies.

Sponsored Publications
Read more
14 June 2016
/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png 0 0 Thomas Gabrielczyk /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Thomas Gabrielczyk2016-06-14 18:09:092016-06-14 18:09:09Humanized NSG and NSG-SGM3 mice as a new preclinical bridge for immune-oncology therapies.
Page 20 of 20«‹181920

LATEST NEWS

Bayer Pharma headquarters in BerlinBruno Coelho - stock.adobe.com

Bayer targets leading position in HER2-positive NSC...

Curevac_2ndgen.jpgGerd Altmann/pixabay.com

From Brisbane to London to Paris: Vicebio´s Sanofi...

Genregulation interaction as targeted by Abivax SA in Colitis ulcerosaAbivax SA

Abivax soars 500% on TOP-Line data

ADVERTISEMENT

MAGAZINE

1 / 4
01_EB225_Titel.indd

This issue focuses on the art of upscaling industrial biotechnology in Europe, the impact of the Trump factor on the life sciences and the European Commission's new billion-euro fund for emerging … more ➔

2 / 4
EB125_Cover

This issue offers insights into Europe's fight for green solutions for a bioeconomy, antimicrobial resistance and how Europe is preparing for the next pandemic. more ➔

3 / 4
EB424_Cover

Since the first antibody drug was approved back in 1986, monoclonal antibodies have emerged as the dominant class in the global US$417bn market for biologics. At the end of 2023, sales stood at more … more ➔

4 / 4
EB324_Titel

The first half of 2024 is history, and experts are divided on whether the financing nadir has been reached or even passed. There are very different figures for different types of treatments under … more ➔

❮❯

SPONSORED PUBLICATION

1 / 2
product_02_bg[63]
Meteor Biotech

Unlocking the Future of Precision Biology with Spatial Cell Sorting

Spatial precision in cell analysis is revolutionizing biomedical research. SLACS (Spatially-resolved Laser Activated Cell Sorting) uniquely isolates live microniches within tissues, preserving spatial … more ➔

2 / 2
Monarch_Advertorial_202502_EU
New England Biolabs

The Bridge to your success

Customized Enzymes and Reagents from New England Biolabs. Creating the right partnership is essential when pioneering a new life science product. more ➔

newsletter_link
© BIOCOM Interrelations GmbH
  • LinkedIn
  • Instagram
  • Contact
  • Imprint
  • Privacy policy
Scroll to top